In cisplatin-resistant human lung cancer cells, FTY720 combined with cisplatin enhanced the antitumor effect of cisplatin on cisplatin-resistant lung cancer cells by down-regulating the expression of Atg7 [19]. The gene discussed is ATG7; the disease is lung cancer.